41
Views
2
CrossRef citations to date
0
Altmetric
Case Report

Elemene treatment for NSCLC with multiple CNS metastases: a case report and literature review

, , , , , & show all
Pages 6377-6382 | Published online: 02 Oct 2018

References

  • KhuntiaDBrownPLiJMehtaMPWhole-brain radiotherapy in the management of brain metastasisJ Clin Oncol20062481295130416525185
  • HubbsJLBoydJAHollisDChinoJPSaynakMKelseyCRFactors Associated With the Development of Brain MetastasesCancer2010116215038504620629035
  • LeeSSKimMKSymSJIntramedullary spinal cord metastases: a single-institution experienceJ Neurooncol2007841858917310265
  • SudoJHonmuraYMeningeal carcinomatosis in patients with lung cancerNihon Kokyūki Gakkai Zasshi2006441179579917144575
  • ClarkeJLPaoWWuNMillerVALassmanABHigh dose weekly erlotinib achieves therapeutic concentrations in CSF and is effective in leptomeningeal metastases from epidermal growth factor receptor mutant lung cancerJ Neurooncol201099228328620146086
  • GrommesCOxnardGRKrisMGPulsatile” high-dose weekly erlotinib for CNS metastases from EGFR mutant non-small cell lung cancerNeuro Oncol201113121364136921865399
  • CessotABlanchetBGoldwasserFErlotinib treatment of meningeal carcinomatosis in lung cancer: more is betterAnn Oncol2014251020932094
  • JackmanDMCioffrediLAJacobsLA phase I trial of high dose gefitinib for patients with leptomeningeal metastases from non-small cell lung cancerOncotarget2015664527453625784657
  • LiQQLeeRXLiangHZhongYQqLAnticancer activity of β-Elemene and its synthetic analogs in human malignant brain tumor cellsAnticancer Res2013331657623267129
  • ChenXWangYLuoHβ-elemene acts as an antitumor factor and downregulates the expression of survivin, Bcl-xL and Mta-1Mol Med Rep20126598999522895653
  • D’AntonioCPassaroAGoriBBone and brain metastasis in lung cancer: recent advances in therapeutic strategiesTher Adv Med Oncol20146310111424790650
  • ClarkeJLPerezHRJacksLMPanageasKSDeangelisLMLeptomeningeal metastases in the MRI eraNeurology201074181449145420439847
  • XimaoLWanshengLMaoqingHuMRI findings of metastatic meningeal carcinomatosisZhongguo CT He MRI Za Zhi2009731518
  • ConnollyESWinfreeCJMccormickPCCruzMSteinBMIntramedullary spinal cord metastasis: report of three cases and review of the literatureSurg Neurol19964643293378876713
  • FindlayJMBernsteinMVanderlindenRGReschLMicrosurgical resection of solitary intramedullary spinal cord metastasesNeurosurgery19872169119153437960
  • OkamotoHShinkaiTMatsunoYSaijoNHiroaki OkamotoTIntradural parenchymal involvement in the spinal subarachnoid space associated with primary lung cancerCancer1993729258325888402479
  • TogashiYMasagoKFukudoMCerebrospinal fluid concentration of erlotinib and its active metabolite OSI-420 in patients with central nervous system metastases of non-small cell lung cancerJ Thorac Oncol20105795095520479691
  • LeeEKeamBKimDWErlotinib versus gefitinib for control of leptomeningeal carcinomatosis in non-small-cell lung cancerJ Thorac Oncol2013881069107423804027
  • UmemuraSTsubouchiKYoshiokaHClinical outcome in patients with leptomeningeal metastasis from non-small cell lung cancer: Okayama Lung Cancer Study GroupLung Cancer201277113413922487432
  • XuYZhongWZhaoJClinical Features of Intradural Extramed-ullary Spinal Cord Metastases in Primary Lung CancerZhongguo Fei Ai Za Zhi201619853954427561805
  • KuribayashiHAbeSKuseNMarked improvement in leptomeningeal carcinomatosis and spinal cord metastases following alectinib treatment of crizotinib-resistant, ALK-positive lung adenocarcinomaI Can Conf J2016526972
  • LeiMLiuYLiuSWangLZhouSZhouJIndividual strategy for lung cancer patients with metastatic spinal cord compressionEur J Surg Oncol201642572873426924783
  • Nicole WhiteMDMetastatic Spinal Cord Compression: Presentation, Diagnosis, and ManagementHospital Medicine Clinics201653452465
  • GiraldoABenaventeSRamosMEffectiveness of radiotherapy for metastatic spinal cord compression in patients with short life expectancyRep Pract Oncol Radiother2017221586327843413
  • BailonOChouahniaKAugierAUpfront association of carboplatin plus pemetrexed in patients with brain metastases of lung adenocarcinomaNeuro Oncol201214449149522362813
  • BearzAGarassinoITiseoMActivity of Pemetrexed on brain metastases from Non-Small Cell Lung CancerLung Cancer201068226426819632738
  • GiorgioCGGiuffridaDPappalardoAOral temozolomide in heavily pre-treated brain metastases from non-small cell lung cancer: phase II studyLung Cancer200550224725416039010
  • DomínguezAÁlvarezASuárez-MerinoBGoñi-de-CerioFNeurological disorders and the blood-brain barrier. Strategies and limitations for drug delivery to the brainRev Neurol201458521322424570360
  • LiLJZhongLFJiangLPGengCYZouLJβ-Elemene radiosensitizes lung cancer A549 cells by enhancing DNA damage and inhibiting DNA repairPhytother Res20112571095109722692988
  • ChenWLuYWuJGaoMWangAXuBBeta-elemene inhibits melanoma growth and metastasis via suppressing vascular endothelial growth factor-mediated angiogenesisCancer Chemother Pharmacol201167479980820563582
  • LiQQWangGZhangMCuffCFHuangLReedEbeta-Elemene, a novel plant-derived antineoplastic agent, increases cisplatin chemosensitivity of lung tumor cells by triggering apoptosisOncol Rep200922116117019513519
  • ZhuYHuJShenFShenHLiuWZhangJThe cytotoxic effect of β-elemene against malignant glioma is enhanced by base-excision repair inhibitor methoxyamineJ Neurooncol2013113337538423700323
  • WangGLiXHuangFAntitumor effect of beta-elemene in non-small-cell lung cancer cells is mediated via induction of cell cycle arrest and apoptotic cell deathCell Mol Life Sci2005627–888189315868411
  • JushengHYinghuiXClinical study on the treatment of intracranial malignancy by β-elemeneChinese Journal of Neurosurgery19944225228
  • JiangHMaSFengJIn vitro study of radiosensitization by β-Elemene in A549 cell line from adenocarcinoma of lungThe Chin-German J Clin Oncol2009811215
  • AilingCAOHailangHEMeta-analysis of Elemene Injection Combined with Radiotherapy in Treating Brain Metastasis of Lung CancerTradi Chin Drug R & C Pharmacol2016276880886